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at specific target sites
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Abstract
Background: Recent technological advances have delivered the genome-wide targets of many important transcription factors (TFs). However, increasing evidence suggests that not all target sites mediate regulatory function, raising
the questions of how to determine which sites are active, what are the epigenetic consequences of TF binding at
these sites, and how the specificity is coded. To address these questions, we focused on CRX, a disease-associated
homeodomain TF required for photoreceptor gene expression and development. Since CRX binds more than 6000
sites across the genome in the retina, we profiled chromatin landscape changes at each binding site during normal
development and in the absence of CRX and interpreted the results by thorough investigation of other epigenomic
datasets and sequence features.
Results: CRX is required for chromatin remodeling at only a subset of its binding sites, which undergo retina or
neuronal specific activation during photoreceptor differentiation. Genes near these “CRX Dependent” sites code for
proteins important for photoreceptor physiology and function, and their transcription is significantly reduced in Crx
deficient retinas. In addition, the nucleotide and motif content distinguish these CRX Dependent sites from other
CRX-bound sites.
Conclusions: Together, our results suggest that CRX acts only at select, uniquely-coded binding sites to accelerate
chromatin remodeling during photoreceptor differentiation. This study emphasizes the importance of connecting TF
binding with its functional consequences and provides a framework for making such a connection using comparative
analyses of available genomic datasets. Finally, this study prioritizes sets of non-coding DNA sites for future functional
interrogation and identification of mutations associated with retinal disease.
Keywords: Retinal gene expression, Photoreceptor development, Crx deficiency, Epigenetic regulation
Background
Development and maintenance of each cell type in our
body requires precisely regulated gene expression, where
a set of genes required for specific cellular structure
and function is activated, but other irrelevant genes are
silenced. This is directed by transcription factor (TF)
networks and their target DNA elements across the
genome. Recent technological advances have delivered
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the genome-wide binding sites of many TFs essential for
a wide range of developmental processes and cell types.
However, our knowledge about how specific TFs work is
still quite limited. For instance, a TF will not bind every
instance of its target DNA motif in the genome. Furthermore, each binding occurrence of the same TF may not
have the same functional consequence or relevance. In
this study, we sought to address these questions using the
retinal and disease relevant homeodomain TF CRX as a
model.
The retina is the highly specialized portion of the central nervous system responsible for initiating and processing visual signals before they are transmitted to the
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brain. The retina consists of six major classes of neurons
and one of glia [1–4]. Rods and cones are the two types
of photoreceptors responsible for the initial conversion
of a photon of light into an electrical signal. Mouse retinas are rod dominant; rods constitute 80% of the retinal
cells, while cones comprise only 2% [1, 5]. Retinal neurogenesis follows a stereotyped developmental program
with specific cell types born in overlapping waves [6].
In mice, rods are born over a long window in time that
peaks at postnatal day 0 (P0) and continues until P2 [6].
Post-mitotic rod precursors undergo differentiation
over an extended 2-week period, during which the cells
establish a rod-specific gene expression profile, develop
unique subcellular structures, and eventually can perform phototransduction.
Precisely regulated gene expression is essential for rod
structural/functional development and survival, as even
subtle perturbations can result in blinding diseases [7,
8]. Rod gene expression is tightly regulated by a number
of transcription factors (TFs), acting in a cascade during development [(Reviewed by Swaroop et al. [9]). The
homeodomain (HD) TF OTX2 specifies the photoreceptor lineage by turning on the expression of cone rod
homeobox (CRX) and its downstream TFs. CRX is an
OTX-like HD TF, whose expression coincides with the
final mitotic event in rod and cone photoreceptors and
is maintained into adulthood [10, 11]. CRX binds to the
promoter of rod/cone genes and activates their expression via its transactivation domain [10, 12]. Two rod-specific TFs, NRL and NR2E3, act with CRX to direct rod
differentiation by activating rod and silencing cone genes
[9, 13–15]. General TFs involved in chromatin remodeling, including MEF2D, CBP/P300, and the STAGA
complex, are also part of the CRX regulatory network
[16–18]. Together, these factors properly establish the
rod epigenome and transcriptome.
CRX is essential for photoreceptor differentiation and
functional development. A Crx null mutation (Crx−/−)
produces a recessive phenotype in the mouse retina
where the immature photoreceptor cells fail to differentiate and begin to degenerate at 4 weeks of age [19]. Mutations in human CRX have been associated with dominant
blinding retinopathies with varying severity and etiology
(Reviewed by Tran and Chen [20]). Interestingly, in the
corresponding mouse models, distinct Crx mutations all
affect the expression of a common set of genes, but the
degree of dysregulation correlates with phenotype severity [7]. The mechanism for this mis-regulation remains
to be determined, but a better understanding of CRX’s
mechanism of action during photoreceptor development
would provide insights into the pathogenicity of human
CRX mutations.
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Chromatin immunoprecipitation with high-throughput sequencing (ChIP-seq) for CRX was performed in
the adult mouse retina [21]. Binding sites were enriched
for a HD binding motif, and authors noted that many
known photoreceptor-specific genes were near binding
sites. These same genes generally lose expression in Crx
mutant retinas [22]. However, while these analyses suggest that those genes are directly controlled by proximal
CRX-binding sites, they fail to explain the function of the
many other CRX-bound sites that are not near affected
genes.
Previous experiments have also investigated the activity
of CRX using plasmid-based assays. Luciferase reporter
assays in heterologous systems have been employed to
map the activation domain, demonstrate the synergy
between CRX and NRL, and determine the functional
effect of CRX mutations [12, 22–24]. Plasmid-based systems have been adapted to report the activity of enhancers in vivo using GFP [21, 25, 26], but these experiments
are limited in scope as each construct must be tested
individually. Recent technological advances have overcome these throughput limitations. Massively Parallel
Reporter Assays (MPRAs) performed in the retina confirmed that hundreds of CRX-bound regulatory elements
positively regulate transcription, while unbound regions
did not [27]. Additional experiments suggested that motif
affinity directly contributed to this regulatory potential
[28]. However, it remains to be seen if these MPRA findings can be translated into the genomic/chromatin context in vivo.
Multiple experiments have sought to understand normal epigenetic development of rods and cones [29–33].
Dramatic developmental remodeling was described by
ChIP-seq of histones and regulatory proteins, and by profiling DNA methylation [30]. Other studies have profiled
DNA accessibility through development or compared
mature rods versus cones [29, 31–33]. While these studies all inferred the relevance of CRX at the many regulatory elements to which it binds, none expressly tested
this in vivo. Other recent efforts have profiled epigenetic
changes in diseased human retina [34]. Most importantly,
this study identified a loss of epigenetic activity at retinal sites with the CRX motif. However, additional experimental tests will be necessary to establish a causative role
of CRX in the disease.
To bridge this gap in the understanding of TF binding versus regulatory potential, here we use ATAC-seq
to show that CRX is only responsible for the epigenomic
rearrangement of a subset of its binding sites. These
“Dependent” sites reside within a variety of chromatin environments and are highly correlated with the
genes affected in mutant retinas. By applying this technique, we clarify the role of this important TF in retinal
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development and disease and provide a model for future
studies of TFs essential to the development of other cell
types.

for visualization in IGV was performed using Samtools
and BEDTools (V2.24.0). For visualization, bedtools slop
function was used to extend reads 300 bp.

Methods

Peak calling and genotype comparison

Animals

Peak calling of ChIP [histone and CRX] and ATAC-seq
data was performed using MACS2 (V2.1.0.20140616).
Peak calling was performed on replicate samples independently. Only peaks that replicated in both samples
were kept, by comparing peak files using the bedtools
intersect function. Intersecting peaks were merged using
bedtools merge function and analyzed for number of
reads within each library using bedtools coverage. Statistical comparison of ATAC-seq data was performed using
EdgeR (V3.18.1). Peaks that did not pass the filter criteria of counts per million (CPM) ≥ 5 in at least 2 samples
were removed prior to the analysis. Filtered count data
were normalized by the EdgeR default normalization
method, TMM, and differential analysis was performed
by the exact test. P-values were subjected to Bonferroni
and Hochberg multiple testing correction to include
false discovery rate (FDR). Peaks deemed to increase or
decrease in the Crx−/− retina were those with a foldchange ≥ 2 and FDR < 0.05.
Replicate histone experimental datasets were normalized to RPM before subtraction of input signal within
peak regions. These values were averaged between replicates for comparison of WT and Crx−/− retina samples.
Analysis and quantification of ATAC-seq and ChIP-seq
data are provided in Additional file 1.

Wild-type and Crx−/− mice (kindly provided by Dr.
Connie Cepko at Harvard University) used for experiments were backcrossed (> 10 generations) to C57BL/6 J
mice obtained from the Jackson Laboratory (Bar Harbor,
Maine; Stock # 000664).
ATAC‑seq library prep and sequencing

ATAC-seq was performed as published in Buenrostro
et al. [35]. Briefly, retinas were dissected from P14 WT
and Crx−/− mice and washed in PBS. Tissue was dissociated at 37C using 2% collagenase in TESCA buffer for
13 min and the reaction stopped by the addition of 2X
volume of DMEM + 10% FBS. DNase I (0.5 Units; Roche,
Basel, Switzerland) was added for the final 3 min to minimize clumping of cells. Cells were counted with hemocytometer and 50,000 re-suspended in TD buffer for a 1 h
incubation with TDE1 (Nextera DNA Library Prep Kit;
Illumina, San Diego, CA) at 37C. Remaining library prep
was performed as published. Libraries were pooled and
sequenced using the Illumina 2500.
Chromatin Immunoprecipitation

Chromatin immunoprecipitation (ChIP) assay was performed as previously described [22]. In summary, 6
pooled P14 C57BL/6 J wild-type or Crx−/− mouse retinas per sample were dissected and chromatin was crosslinked with 1% formaldehyde in PBS for 10 min at room
temperature. Cross-linked cells were lysed and fragmented by sonication. Chromatin fragments were immunoprecipitated with the antibodies to H3K27ac (Abcam,
Cambridge, UK; ab4729) and H3K4me3 (Millipore
Sigma, Burlington, MA; 07-473), or normal rabbit/mouse
IgG (Santa Cruz Biotechnology, Dallas, TX) bound to
Protein A beads (Millipore, 16-125) or A/G beads (Santa
Cruz Biotechnology). After extensive washing, the immunoprecipitated chromatin was eluted, heated to 67 °C to
reverse the cross-links, and the DNA-purified by ethanol
precipitation. Libraries were prepared using the DNA
SMART ChIP-Seq Kit (Clonetech, Mountain View, CA).
10 ng of ChIP DNA was used as input for each sample.
Mapping of ATAC‑seq and ChIP‑seq data

Libraries were de-multiplexed according to barcodes
inserted in the P7 adaptor and mapped to mm9 using
Novoalign (V3.04.06). Alignments were cleaned using
Samtools (V1.3.1); duplicate and reads mapping to mitochondrial genome were removed. All other processing

Detection of overlapping ChIP, ATAC, and ChromHMM
location

All co-localization detection of genome-wide datasets
was performed using the bedtools intersect function.
ChromHMM bed files were graciously provided by Dr.
Issam Aldiri, St. Jude’s Children’s Research Hospital.
Read coverage epigenetic analysis

Heatmaps and line graphs depicting epigenetic data were
generated using the UNIX software package HOMER
(V4.7) [36]. Heatmaps were generated by importing the
HOMER-generated counts back into R and visualized by
the heatmap.2 function in the gplots (V3.0.1) R package.
Line graphs plotting average signal were computed from
this data in R. Statistical comparison and plotting of data
was performed using GraphPad Prism software (V7.0b).
Motif calling

Known motif analysis was performed using Transcription Factor Affinity Prediction (TRAP) web Tools [37].
Analysis was performed on Jaspar vertebrate matrix file,
with mouse promoter background model, and multiple
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test correction was Benjamini–Hochberg. Heatmap visualizes the −log(10)-converted corrected p-value of each
TF motif. De novo motif analysis was performed using
the HOMER findmotifsgenome tool (V4.7).
BEEML calculation of affinity

Analyses were performed as in White et al. [28]. Custom
scripts to calculate TF affinity were graciously provided
by authors. Statistical comparisons of results were performed in R.
Nucleotide density and motif density

All analyses were centered on the CRX ChIP peak and
utilized the HOMER annotatepeaks function. Matrix
outputs from de novo motif analysis were tested for motif
density using the HOMER annotatepeaks function in
20 bp windows.
Conservation

All analyses were centered on the CRX ChIP peak and
utilized data downloaded from UCSC genome browser
(phastCons30way Vertebrate Conservation). Plotted data
represent mean of a running 20-bp window across the
peak region.
Gene ontology (GO) analysis

Gene ontology (GO) analyses were performed using the
GREAT tool (Ver 3.0) [38]. Peak files used were centered
on the CRX-binding site, and associations were with the
settings “single nearest gene” and no limit on distance.
These same associations were used as the basis of regulatory site to gene association for RNA-seq comparisons.
RNA‑seq

RNA-seq data were obtained from GSE52006. Data
were analyzed as described previously in Ruzycki et al
(2016) [7]. Briefly, 1 × 42 bp reads were aligned to the
mouse genome (version mm9) with the sequence aligner
TopHat2 (version v2.0.5) using the following parameters:
-a 5 -m 1 -i 10 -I 500000 -r 100 –p 4 –microexon-search –
no-coverage-search -× 20 –segment-length 25. Dependencies included Bowtie (v0.12.8) and Samtools (v0.1.18).
Bedgraph files were generated using BEDTools (v2.23.0)
and visualized using IGV (V2.3.20). The HTSeq package (version 0.6.1p1) was used to assign aligned reads
to the gene annotation reference track (UCSC Genes
Track, UCSC Table Browser, NCBI37/mm9, accessed
July 16, 2014). This generated a raw read count per gene
which was used in EdgeR [39] for detecting differentially
expressed genes. For each of the genotype comparisons, genes that did not pass the filter criteria of counts
per million (CPM) ≥ 5 in all replicates of at least one
comparison Group were removed prior to the analysis.
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Filtered count data were normalized by the EdgeR default
normalization method, TMM, and differential expression analysis for each of the comparison groups was
performed by the exact test. P-values were subjected to
Bonferroni and Hochberg multiple testing correction to
include false discovery rate (FDR). Downstream analysis
was performed using custom Perl and R scripts.

Results
CRX binds ATAC‑sensitive regulatory sites

To determine active regulatory regions in the genome
of mouse rod photoreceptors, we performed whole retina ATAC-seq [35], a technique that profiles open chromatin regions. We chose to profile at postnatal day 14
(P14), because all retinal cell types are born by this age
[6] and photoreceptor specification is completed. Replicate experiments on whole retina of C57BL/6 J (WT)
mice, where rods comprise ~80% of the cells [1, 5], were
highly reproducible (r = 0.99) and very consistent with
ENCODE DNase I hypersensitivity profiles of adult (8wk)
whole retina (r ≥ 0.92) (Fig. 1a and Additional file 2: Fig.
S1) [29, 33].
We overlapped these regulatory sites (ATAC-seq
peaks) with sites bound by CRX (detected by ChIPseq) [21]. The majority (>98%) of CRX-bound sites were
contained within ATAC-sensitive genomic regions, but
many ATAC-sensitive sites showed no CRX enrichment
(Fig. 1a, b).
To understand the role of these regulatory elements, we
first analyzed their distribution around the transcription
start site (TSS) of each gene expressed in the retina in the
context of that gene’s dysregulation in Crx−/− cells. Figure 1c, d plots the TSS +/− 10 kb of each gene ordered
along the y-axis by the expression change in the Crx−/−
(detailed on left-most panel). Figure 1c details the center
of every ATAC-sensitive regulatory site (black dots), the
distribution of which is quantified by histograms along
the top and right of the plot. As expected, these sites display a strong preference to be located near the TSS and
there was no preference for these sites to be near genes
that were differentially regulated in the Crx−/− retina.
We also plotted in the same manner only the subset
of ATAC regions bound by CRX (Fig. 1d). These sites
showed a similar preference to be located near the TSS.
However, we were surprised to find that while there was
some preference for genes that lose expression in the
Crx−/− retina (excess distribution near bottom of plot),
many CRX-bound sites were near genes that are not transcriptionally affected upon its loss. These data suggested
that while CRX is a strong transcriptional activator [10],
not every binding site has the same regulatory potential
or dependency upon CRX activity.
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Fig. 1 CRX binds a subset of active regulatory sites in the rod photoreceptor. a Browser track displays ATAC-seq, DNase I, and CRX ChIP-seq read
depth. (Scale bar 5 kb) b Venn diagram depicting number of CRX ChIP-seq-defined binding sites that overlap with regulatory sites defined by
ATAC-seq. (c, d) Meta-gene plots of all genes expressed in P21 WT and Crx−/− retinas, ordered by [log2] fold-change (as detailed on left). Black dots
represent the center of ATAC regulatory site relative to TSS of c all ATAC peaks and of d only the subset bound by CRX. Histograms on X and Y axes
display density and distribution of the data points

Crx−/− retinas have an altered photoreceptor epigenome

To determine the functional implications of the loss
of CRX on the epigenome of photoreceptors, we also
performed duplicate ATAC-seq experiments on P14
Crx−/− retinas and compared the results to those of WT
retinas. Again, Crx−/− replicates were highly consistent
with one another (Fig. 1a and Additional file 2: Fig. S1).
Although many of the ATAC peaks qualitatively resembled the WT signal, some (e.g., those spanning Gnat1)
appeared much weaker in Crx−/− than WT (Fig. 1a).
Since no photoreceptor degeneration or cell death is
detected in Crx−/− at this age [19, 22], differential
ATAC signals between the two mouse lines are indicative of changes in the photoreceptor epigenome. Indeed,
by quantitative comparison of WT and Crx−/− datasets,
Crx−/− retinas display a widely disturbed epigenome
with both increased (“up”) or decreased (“down”) activity at potential regulatory sites (Fig. 2a). Roughly 25% of

ATAC peaks were altered, with virtually equivalent proportions “up” as those that were “down” (Fig. 2b).
Crx−/− photoreceptors fail to close and open
developmentally modulated regulatory sites

Previous DNase I hypersensitivity data analyzed three
stages of retinal development: P1, P7 and Adult [29,
33]. Because of the overrepresentation of rods in the
mouse retina, we can generalize these samples to represent precursor, immature, and mature rod photoreceptors, respectively. Comparison to these datasets
delineated distinct patterns in each class of genomic
sites (Fig. 2c–e and Additional file 3: Fig. S2). Sites
that were not changed between WT and Crx−/− were
already open at early stages (Fig. 2d and Additional
file 3: Fig. S2b). However, sites that are affected display contrasting dynamics over the course of development: The set that loses activity in the Crx−/− retina
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Fig. 2 Loss of CRX affects many developmentally remodeled regulatory sites. a, b Comparison of WT and Crx−/− ATAC-seq data shows highly
disturbed epigenome in Crx−/− retinas where significant numbers of sites display increased (red) or decreased (blue) signal. c, e Read density
heatmaps display reproducibility of ATAC experiments (WT 1 & 2 vs. Crx−/− 1 & 2), overlap of CRX binding signal, and regulatory activity as defined
by DNase I in P1, 1wk, and 8wk retina, brain, and liver samples. f Scatterplot displays distribution of the subset of CRX-bound ATAC sites (black dots)
relative to all WT versus Crx−/− ATAC-sensitive sites (gray). g Proportion of total sites within each ATAC class bound by CRX (black) are displayed in
pie charts

normally would be activated, while the set that gains
activity in the mutant retina would be closed over normal development (Fig. 2c vs. 2e and Additional file 3:
Fig. S2a vs Fig. S2c).

These sites also show differential tissue specificity.
When compared to other DNase I data, unaffected sites
are also generally active in the brain and liver (Fig. 2d).
Again, affected sites show contrasting patterns, where
those that lose accessibility in Crx−/− retinas are largely
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retina specific (Fig. 2e), while those that gain accessibility in mutant retinas are also very active in the brain
(Fig. 2c). These data suggest that Crx−/− retinas maintain a majority of their basic epigenetic state that would
be similar in all cell types. However, they fail to activate
highly photoreceptor-specific set of sites and to inactivate
many sites that are used generally in unspecified neurons.
Next, we tested what types of genes were likely regulated by these sites (Additional file 4) [38]. “Down” sites
are highly enriched for gene ontology (GO) categories
involved in “phototransduction,” “detection of light,” and
microtubule-related processes. “Up” sites were enriched
for categories involving general development or differentiation of oligodendrocytes, somatic motor neurons, and
peripheral nervous system. There was also an enrichment
for a single retinal-related category “detection of visible light.” Further investigation discovered the enriched
genes to primarily be cone related (Cnga, Cngb, and
Gnat2, among others), which are present in developing
“immature” rods or transfated S-cones in the absence of
NRL [13, 40].
CRX binding is strongly enriched at sites that lose activity
in Crx−/−

To understand the primary role of CRX in this dynamic
chromatin environment, we classified ATAC sites
based on the presence of an overlapping CRX ChIP signal (Fig. 2f, g). Nearly half of the ATAC peaks that are
reduced in the Crx−/− retina are bound by CRX [CRX
Dependent] compared to a very small fraction (< 1%) of
those ATAC peaks that show increased signal (Fig. 2f, g
and 2c vs. e). There was also a significant enrichment of
CRX binding within ATAC sites that were unchanged in
the Crx−/− retina [CRX Independent] (Fig. 2d, f, and g;
Table 1).
We next sought to determine the relationship between
changes in ATAC-measured accessibility and local gene
expression. CRX-bound sites with decreased ATAC signal in Crx−/− compared to WT show a strong preference
for the TSS of genes that lose expression (Fig. Additional
file 5: Fig. S3f ). A similar trend was also observed for
non-CRX-bound sites that lose ATAC signal in Crx−/−
retina (Additional file 5: Fig. S3e). Conversely, ATAC sites
that show increased accessibility in the Crx−/− retina,
Table 1 ATAC-seq peaks lost in Crx−/− show enrichment
for CRX binding in WT
Total
Up
No change
Down

CRX-bound

%

6259

33

0.5

32,105

3883

12.1

4586

1992

43.4

nearly all of which lack CRX binding, are greatly enriched
near genes that increase expression in the Crx−/− retina
(Additional file 5: Fig. S3a and S3b). Sites unchanged in
the mutant retina show no strong association with any
changes in gene expression (Additional file 5: Fig. S3c and
S3d). Together, these data show the strong correlation
between local regulatory site activity and gene expression, but highlight differences in CRX-binding sites.
CRX acts within a variety of chromatin environments

We decided to explore the differences between these
CRX-binding sites that were lost [CRX Dependent] versus maintained [CRX Independent] in the Crx−/− retina. Previous studies have classified TF binding sites into
promoter or enhancer classes based on distance from
the TSS. This approach is straightforward, but with new
studies showing the breadth of local regulatory domains
[41, 42] and the unique TSS usage of photoreceptors [43]
it likely does not reflect the true biology or regulatory
role of each site. Instead, we decided to distinguish binding sites based on the local epigenetic state. CRX-binding
sites were located in four distinct chromatin environments defined by ChIP-seq of H3K4me3 and H3K27Ac at
P14 in WT retinas (Fig. 3a, b). Groups A and C represent
the largest proportion of the CRX-binding sites and are
located in local regulatory domains and distal enhancers, respectively (Fig. 3). Group D represents CRX sites
where neither active histone mark is present, and these
are located similar to distal enhancer Group C, far from
annotated genes (Fig. 3c). Group B includes a very small
number of CRX sites that are near genes expressed at a
very low level (Fig. 3c and Additional file 6: Fig. S4). We
found a relatively equal representation of CRX Dependent and Independent sites within the three main Groups
(Table 2), although Group A displayed some overrepresentation of Independent sites.
CRX is required to activate a subset of local regulatory
regions

To investigate the differential influence of CRX at local
regulatory regions (Fig. 3; Group A), we first analyzed
the temporal changes in the activation state as profiled
by DNase I (Fig. 4 and Additional file 7: Fig. S5). CRX
Dependent sites show strong retinal specificity and developmental activation (Fig. 4a (left panel), Additional file 7:
Fig. S5a). This pattern is in stark contrast to Independent sites that display strong signal also in brain and liver
samples and retinal accessibility at all ages (Fig. 4a (right
panel), Additional file 7: Fig. S5b).
To further explore the epigenetic state of these sites
over normal retinal development, we analyzed recently
published ChromHMM data (Additional file 8: Fig. S6)
[30]. By analyzing individual ChIP datasets (data not
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Fig. 3 CRX binds within four chromatin environments. a Pie chart depicts number of CRX-binding sites that reside within Groups A–D as defined
by overlap with (b) ChIP-seq data of H3K4me3 and H3K27Ac datasets in P14 WT retina. c Lines represent proportion of peaks within Groups A–D in
each distance bin relative to nearest annotated TSS

Table 2 Regulatory sites are either Dependent or Independent
of CRX action
Dependent

Independent

Group A

776

2445

Group B

3

150

Group C

998

1133

Group D

234

287

shown) and the aggregate of this data in the HMM classification of the binding sites (Additional file 8: Fig. S6a
and S6b), we found that Independent sites were nearly
all classified as active HMM classes throughout development, while Dependent sites displayed temporal remodeling up to P7.
To determine whether the loss of CRX affected the
local histone modifications at Dependent sites, we

performed ChIP-seq for H3K4me3 in WT and Crx−/−
retinas. Peaks containing CRX Independent sites largely
maintained H3K4me3 presence in mutant retinas, while
peaks containing CRX Dependent sites display a significant loss of signal in Crx−/− (Fig. Additional file 7: Fig.
S5c and S5d).
We sought to determine the effects of these epigenetic
changes on gene expression. RNA-seq data profiling WT
development and changes in Crx−/− were consistent
with ATAC and DNase I data. Genes near CRX Independent sites show few developmental expression changes
and are relatively unaffected in mutant retinas. In contrast, those near Dependent sites increase dramatically
over development but largely fail to do so in the Crx−/−
(Fig. 4b). Gene ontology (GO) analysis of these genes suggests Dependent genes are largely photoreceptor related,
while the Independent set comprises some genes with
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Fig. 4 CRX is only required for activity and remodeling of a subset of Group A local regulatory sites. a Plots display read density of DNase I
experiments centered on CRX-binding site of Dependent and Independent Group A sites. b Analysis of RNA-seq of nearest gene to each peak,
displayed as boxplot of normalized RPKM values at P2 and P21 in WT and P21 in Crx−/−. (Wilcoxon rank sum test, paired; *p < 0.05, **p < 2.2 × 10−5,
***p < 2.2 × 10−10, ****p < 2.2 × 10−16)

photoreceptor function, but also genes with more general
functions (protein transport, RNA processing, protein
localization, etc; Additional file 4).
CRX is required to activate a set of distal enhancers

CRX also binds sites marked uniquely by H3K27Ac
(Fig. 3; Group C), traditionally thought to be active distal
enhancers. Dependent and Independent sets of enhancers both displayed dynamic changes over development
and a high degree of retinal specificity (Fig. 5a and Additional file 9: Fig. S7a and S7b). However, by closer comparison of the temporal dynamics of this activation, we
observed that Independent sites showed earlier activation than Dependent sites (Additional file 9: Fig. S7a and
S7b). HMM classification was nearly identical by P14, but
comparison of P0 and P3 data showed Independent sites
switch to active classifications earlier than Dependent
(Additional file 8: Fig. S6c and S6d).
To test whether ATAC signal changes correlated
with the mutant epigenome, we performed ChIPseq for H3K27Ac at P14 in WT and Crx−/− retinas.
As expected, Dependent sites displayed a significant
decrease in H3K27Ac deposition in Crx−/− retinas,
while Independent sites largely maintained this mark
(Additional file 9: Fig. S7c and Additional file 9: Fig. S7d).
Expression of the nearest gene to each enhancer also
highlights differences between CRX-binding sites. Genes
near both Dependent and Independent sites increased

in expression over development in WT retinas (Fig. 5b).
However, this increase is attenuated upon loss of CRX
only in the Dependent set (Fig. 5b). GO analysis showed a
very clear distinction where Dependent genes are photoreceptor related, while Independent genes have a variety
of general functions (Additional file 4).
CRX controls distal regulatory sites in the absence of active
histone marks

A significant number of CRX-bound sites were not
marked by either H3K4me3 or H3K27Ac (Fig. 3; Group
D). When we analyzed the DNase I and HMM data
at these sites, the pattern looked similar to Group C
enhancers where CRX Dependent sites opened later than
Independent and were more retina specific (Additional
file 8: Fig. S6e, f; Additional file 10: Fig. S8a, d, e). One
notable difference was that HMM classification highlighted a subset of Independent sites classified throughout development as Class 11 [Insulator] (Additional file 8:
Fig. S6e).
Interestingly, gene expression data highlighted a different scenario than other groups. The expression of
the nearest gene to CRX Dependent sites displayed
no significant differences (Additional file 10: Fig. S8b).
While differences in gene expression were statistically
significant in the Independent set, the degree of change
was very modest.
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Fig. 5 CRX activates a subset of Group C distal enhancers over development. a Plots display read density of DNase I experiments centered on
CRX-binding sites of Dependent and Independent Group C sites. b Analysis of RNA-seq of nearest gene to each peak, displayed as boxplot of
normalized RPKM values at P2 and P21 in WT and P21 in Crx−/−. (Wilcoxon rank sum test, paired; *p < 0.05, **p <2.2 × 10−5, ***p < 2.2 × 10−10,
****p < 2.2 × 10−16)

Base composition and conservation differentiate CRX sites

Our epigenome analyses identified distinct types of CRX
sites, but raised the question of whether sequence characteristics “code” for these differences. As base composition, such as CpG density, can determine the general
regulatory role of genomic locations, we analyzed nucleotide frequency across CRX regulatory sites (Fig. 6a).
Group A Dependent sites show a fairly equal nucleotide
distribution, especially within the central 200 bp of the
CRX-bound regulatory site. This is in dramatic contrast
to the Independent Group A sites that are within highly
GC rich regions. Group C and D distal regulatory elements did not show obvious differences between Independent or Dependent sites. Both have balanced content
within the regulatory site, but lie within AT-rich domains.
We also analyzed the extent to which the sequences
were conserved across vertebrate evolution (Fig. 6b). All
groups display a central region that is more conserved
than the surrounding environment, supporting the
importance of the ATAC- and CRX ChIP-specified regulatory sites. However, Independent sites in Groups A and
C showed significantly higher conservation than their
Dependent counterparts.
CRX has different affinity for Dependent
versus Independent sites

We next sought to determine whether the predicted
binding affinity of CRX could distinguish sites. We first

noted that all CRX-bound sites were strongly enriched
for the presence of a canonical CRX HD site compared
to all ATAC-sensitive sites (Additional file 11: Fig. S9a).
However, there were also significant differences that
distinguished Dependent versus Independent sites. In
Group A proximal regulatory regions, significantly more
Dependent than Independent sites contained the canonical CRX site (Additional file 11: Fig. S9a). This difference
was reflected in the CRX ChIP-seq, where Dependent
sites show a higher read depth (Additional file 11: Fig.
S9b). Group C and D sites displayed the opposite characteristics, where Independent sites were more likely
to contain the CRX motif (Additional file 11: Fig. S9a),
although there was no clear difference in the intensity of
the original ChIP data (Additional file 11: Fig. S9c and
S9d).
We also predicted CRX affinity using an algorithm that
takes into account the relative ratio of protein to DNA
[28, 44]. At both low and high ratios (μ values), Group
A Dependent sites displayed higher binding affinity than
Independent sites (Fig. 6c, d). However, when Groups
C and D were analyzed at a low protein to DNA ratio
(μ =0.5), Independent sites have a significantly higher
affinity score, consistent with the traditional motif search
data (Fig. 6c). When analyzed at a higher ratio, this relationship inverted and Dependent sites instead showed
a higher predicted affinity (Fig. 6d). This suggests that
Dependent distal regulatory sites have more low-affinity
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Fig. 6 Sequence analyses differentiate Dependent and Independent sites. a Nucleotide density and b conservation scores display differences
between Groups A, C, and D and between Dependent and Independent classes of CRX sites in each Group. Both are calculated in 20-bp windows
+/− 1 kb from center of CRX peak. (Two-way ANOVA with Tukey multiple comparison testing; ****p < 0.0001) c, d CRX affinity scores, as defined by
BEEML algorithm are displayed for two DNA/protein ratios (μ values). (Red line denotes median; Wilcoxon rank sum test, *p < 0.05, **p < 2.2 × 10−5,
***p < 2.2 × 10−10, ****p < 2.2 × 10−16)

CRX-binding sites that could additively contribute to
CRX recruitment or direct functional differences.
Other TFs may compensate or be more influential
at Independent sites

We also wondered if binding sites for other TFs could differentiate CRX Dependent versus Independent sites. We
analyzed ± 100 bp from the center of each CRX peak for
enrichment of sequences de novo (Additional file 12) and
motifs in the JASPAR database (Additional file 13: Fig.
S10a). Both methods reported the highest enriched motif
in all groups to be a canonical homeobox (Additional
file 13: Fig. S10a [marked by *] and Additional file 12).

The most striking difference we noted by both methods
was a unique enrichment of many TF motifs in Group A
Independent sites. Known TFs included KLF4, ELK1/4,
E2F1, and NFYa (Additional file 13: Fig. S10a [marked
by **]), while de novo motifs included promoter elements
(GC-box), NFY, NRF1, BHLH, among others (Additional
file 12).
The other five sets shared enrichment of many known
factors including GATA, LHX, and NKX family motifs
(Additional file 13: Fig. S10a), although there were also
notable differences. Both methods suggested an enrichment of CTCF specifically in Group D Independent sites
(Additional file 13: Fig. S10a [marked by ***] and Additional file 12), and known motif analysis suggested that
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ESRRB and FOXC1 are enriched only in Dependent sites
(Additional file 13: Fig. S10a [marked by ****]). De novo
methods also indicated strong unique enrichment of
NEUROD1, MEF2D, and MEIS1 motifs in Group C Independent sites (Additional file 12).
To confirm and explore the relevance of the motif analysis, we chose to focus on the enrichment of MEF2D and
CTCF sites. The CTCF motif was enriched only in Group
D Independent sites by both methods. As previously discussed, this set contains many sites with Insulator function (Additional file 8: Fig. S6e [HMM Class 11 purple]).
We reanalyzed CTCF ChIP-seq data and confirmed that
CTCF binds at Group D Independent sites throughout
development, and this binding was reasonably specific
with minimal enrichment at Independent Group A sites
but none at any Dependent sites (Additional file 13: Fig.
S10c and S10d).
We also explored the enrichment of the MEF2D motif
in Group C Independent sites (Additional file 12). Analysis of previously published ChIP-seq data [16] showed
that MEF2D binds both Dependent and Independent
enhancers in WT retina, but this signal is dramatically
reduced only at Dependent sites in the Crx−/− retina
(Additional file 13: Fig. S10b). Together, these data support the relevance and interpretation of the motif enrichment analyses.

Discussion
Activity defines two types of CRX‑binding sites

By comparing the genome-wide activity changes in WT
versus Crx−/− retinas, we have determined that the loss
of CRX causes significant changes in activity at ~ 25% of
all regulatory sites. Even though CRX is an activating TF,
sites that increase were as prevalent as those that lose
activity (Fig. 2). By analyzing these sites alongside time
course DNase I hypersensitivity data, we have confirmed
previously hypothesized mechanisms of CRX-associated
disease, that the rod photoreceptors are stuck in a predevelopmental state; sites that were supposed to close
remain active, and sites that were supposed to progressively open did not do so (Fig. 2e–g and Additional file 3:
Fig. S2). This model of CRX disease explains previous
findings that Crx mutants aberrantly express “cone”related transcripts [7]. Together with this data, recent
reports that suggest a more common developmental
path of rods and cones than previously recognized [45]
support the model that Crx mutant retinas resemble a
premature state prior to the dramatic epigenetic switch
toward rod photoreceptor identity.
Many of the peaks that lose activity are normally bound
by CRX itself (Fig. 2f, g), consistent with these sites
being Dependent on its activity. CRX showed virtually
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no binding at peaks with increased activity, but surprisingly did bind many peaks that were unchanged, or Independent (Fig. 2c, d). Our method that incorporates other
aspects of the local epigenetic neighborhood, including two active histones, clearly establishes distinct types
of CRX-binding sites beyond simply TSS proximal and
TSS distal. We propose this classification system is more
informative and biologically relevant.
CRX is activated in early born photoreceptors and
maintains expression in mature cells. Both developmental DNase I and HMM classifications showed that all
CRX Dependent sites normally undergo dramatic activation over retinal development. By ChIP-seq, we showed
that H3K4me3 and H3K27Ac marks were lost at Group
A and C Dependent sites, respectively, and by RNA-seq,
that nearby genes were not properly activated over development in Crx−/− retina. Together, this suggests that
CRX is involved in this activation likely through its direct
binding and recruitment of other general TFs and coregulators. Previous work has already shown clear roles
of such co-factors including CBP/P300, Ataxin7-STAGA,
DNMT1 in retinal development [17, 18, 46, 47].
Sequence features distinguish CRX Dependent sites

Independent sites showed two very different patterns
(Fig. 7). Group A (TSS proximal) Independent sites were
open constitutively. These regions showed no evidence
of developmental remodeling and were also active in
other tissues. This suggests that these sites are generally
used regulatory elements, and GO analysis of the nearby
genes supports this interpretation as these genes were
categorized as having very general cellular functions.
Conversely, Independent Group C and D sites display
temporal activation and retinal specificity, but quantitative analysis of the DNase I and HMM data suggests
they begin remodeling prior to CRX expression and their
respective Dependent Group sites. The ability of the photoreceptor to maintain or continue activating these Independent sites and properly express nearby genes suggests
that the binding of CRX here is not essential. However,
we cannot formally exclude the possibility that other
homeodomain TFs (such as OTX2) compensate in the
Crx−/− retina.
We analyzed the affinity of CRX by two distinct methods. Both predict that CRX binds more efficiently to
Dependent than Independent Group C sites, which was
supported by ChIP-seq data (Additional file 11: Fig. S9).
We were surprised to find that Dependent distal elements (Groups C and D) display fewer high but more
low-quality motifs. Differences in activity relevant to
binding affinity have been predicted for CRX [28]. This
difference could establish a fundamental mechanism for
CRX activity at enhancers, but alternative biochemical
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Fig. 7 Model synthesizes new insights into difference in CRX activity and mechanism of action at CRX Dependent versus Independent proximal
and distal regulatory sites. The model describes differences in activity state over time (left), and distils motif analysis and base conservation data

experiments would be necessary to study binding efficiency, on/off rates, and functional effects of these different types of sequences.
De novo motif analysis did not reveal any differences
in the HD motif between Dependent and Independent sites. This is not unexpected, as this motif is shared
among many HD TFs expressed throughout the body,
including others expressed in the retina (OTX2 in particular). These results together suggest that CRX binding is directed by the presence of a strong consensus HD
motif, but this association cannot be blindly interpreted
as an important functional interaction (Fig. 7). At Independent regulatory sites, CRX binding may simply be the
by-product of accessibility of a HD element bound by
another HD TF either in the retina or important in other
cell types. Only the precise mutation of these elements in
the genomic context can answer this question.
Previous work had noted that CRX bound within many
GC-rich genomic regions [21]. Our analysis discovered
that these constitute proximal Independent regulatory
sites. While GC-rich areas are normally thought to represent repressed CpG islands, other reports have noted
that ubiquitously expressed promoters display high GC
content while cell-type-specific promoters are AT rich
[48]. We expected that CRX Dependent sites would be
very highly conserved across species. While it was the
case that the regulatory elements were more conserved
than flanking sequences, Independent sites were more
conserved than Dependent counterparts. De novo and
known motif analyses discovered that Independent
sites, especially Group A promoters, were enriched for

a variety of TF motifs. Together, these data suggest that
Independent sites are activated in other cell types of the
body and are regulated by shared or more general TFs.
Analysis of Dependent sites did suggest several CRX
interacting partners, although motifs for known partners
NRL and NR2E3 that synergize or bind with CRX [12, 49]
were not observed. This supports the model that while
all three factors are necessary for proper gene expression, CRX acts as the primary sequence specific targeting factor for the three as a complex. This is supported
by analysis showing that ChIP-seq of NRL largely recapitulates that of CRX (Ruzycki and Chen, unpublished
results). Group C sites in particular displayed enrichment
for a number of other factors including NKX, ESRRB,
and FOXC. These could represent new TFs that either act
in coordination with CRX to activate these enhancers or
could represent pioneer factors that opened the sites to
allow for CRX to bind and fully activate.
Our analyses have emphasized that not every TF binding site is equal. While CRX or any other homeodomain
TF may bind thousands of sites, only a subset of those
sites (for CRX, < 1/3) require the TF to establish or maintain the local epigenetic state. We propose these elements and the homeodomain motifs within Dependent
sites are excellent candidates where non-coding variants
may cause human retinal disease. Our findings are based
on an embryonic loss-of-function study. In this setting,
CRX acts as an “acceleratory factor” required for enhancing Dependent site activity. However, these experiments
do not address whether CRX is sufficient for achieving
the active chromatin state and when CRX’s epigenomic
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activity is required. Ectopic expression of CRX in cultured HEK293 and Y79 retinoblastoma cells failed to produce a rod-like epigenome, even with co-expression of
NRL (Ruzycki and Chen, unpublished results), suggesting CRX is not a “pioneer” factor that can bind to fully
closed sites to induce de novo chromatin remodeling for
cell fate specification. Instead, CRX appears only able
to act on sites that have been “primed” for photoreceptor rearrangement in the precursor cells. Indeed, even
CRX Dependent sites show some level of ATAC sensitivity, perhaps evidence for prior opening by another factor,
although we cannot exclude that this is the result of some
compensation by another TF in the absence of CRX.
Future studies, such as temporal knockout or ectopic
expression of CRX in developing or mature photoreceptors, are needed to address the sufficiency and plasticity questions, important for understanding and treating
CRX-linked diseases.

Conclusions
Our in-depth analysis of the epigenomic function of CRX
highlights the complex nature of TF-mediated gene regulation. Our data specify the subset (~ 1/3) of sites bound
by CRX in vivo that require CRX for proper epigenomic
activation. While our study focuses on the role of a specific TF, CRX, during retinal development, our findings
uncover novel principles that are likely applicable to TFs in
other tissue systems. Our methods also illustrate the utility
of aggregating newly generated data with publicly available
datasets as a powerful way to reveal potential mechanisms
for TF activity and pinpoint candidates for further study.
Additional files
Additional file 1. Analysis and quantification of ATAC-seq and ChIP-seq
data. Excel sheets report; ATAC-seq peaks and genotypic comparison, CRX
ChIP binding sites and classification into Groups A–D, and histone ChIPseq quantification.
Additional file 2: Fig. S1. ATAC-seq data show strong correlation
between replicates and with Dnase I hypersensitivity data. Scatterplots
display normalized read counts (CPM) within ATAC-seq determined regulatory sites, and values represent pairwise Pearson correlation coefficient
Additional file 3: Fig. S2. Affected regulatory sites show distinct changes
in activity over normal retinal development. Plots depict average (black
line, gray bars +/- SEM) of Dnase I hypersensitivity data presented in
Fig. 2c–e for three ages indicated of sites increased (a) not changed (b)
or decreased (c) in the Crx−/− retina compared to WT. (Two-way ANOVA
with Tukey multiple comparison testing; ****p <0.0001
Additional file 4. GO analysis describes differences in nearest gene to
each regulatory site. Sheets within the table represent distinct comparisons referenced within the text.
Additional file 5: Fig. S3. CRX-bound ATAC peak signal changes correlate
with expression changes of nearby genes. (a, c, e—left panel) Meta-gene
plots of all genes expressed in P21 WT and Crx-/- retinas, ordered by [log2]
fold-change (as depicted in plot on left). Black dots represent the center
of ATAC regulatory site relative to TSS of all ATAC peaks not bound by CRX
(a, c, e—right panel) and of only the subset bound by CRX (b, d, f). Peaks
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are divided by their changes in ATAC signal sites increased in Crx-/- relative
to WT (a, b), those that are not changed (c, d), and those that decrease in
Crx−/− (e, f). Histograms of X and Y axes display density and distribution
of the d.
Additional file 6: Fig. S4. Distinct group-related genes show different
expression values. Boxplots represent normalized expression (RPKM) of
the nearest gene to each peak within Groups A–D.
Additional file 7: Fig. S5. CRX is required to activate Dependent Group
A local regulatory elements and to remodel chromatin. Plots display
mean (black line) and SEM (gray bars) of DNase I data presented in Fig. 4a
for CRX Dependent (a) and Independent (b) sites. (Two-way ANOVA
with Tukey multiple comparison testing; ****p <0.0001). c Scatterplot
displays changes in H3K4me3 deposition at all peaks (light gray). Black
and red denote the subset of H3K4me3 peaks that contain Independent and Dependent Group A sites. d Quantification of the fold-change
of H3K4me3 deposition in WT versus Crx−/−. (Wilcoxon Rank Sum Test;
****p < 2.2 × 10−16).
Additional file 8: Fig. S6. Dependent and Independent sites show different chromatin state dynamics. (a, c, e) Stacked bargraphs represent
proportion of Group A–D sites that are contained within each HMMdefined chromatin state at 8 developmental ages. (b, d, f) Quantification
of data binned into HMM classes 1–4, 5–7, 8–10, and 11, for Dependent
and Independent sites show different dynamics of reorganization over
development. Legend defines basic classification of HMM classes [30].
Additional file 9: Fig. S7. CRX is required to activate Dependent Group
C enhancer elements and remodel chromatin. Plots display mean (black
line) and SEM (gray bars) of DNase I data presented in Fig. 5a for CRX
Dependent (a) and Independent (b) sites. (Two-way ANOVA with Tukey
multiple comparison testing; **** p<0.0001) (c) Scatterplot displays
changes in H3K27Ac deposition at all peaks (light gray). Black and red
denote the subset of H3K27Ac peaks that contain CRX Independent
and Dependent Group C sites. (d) Quantification of the fold-change
of H3K27Ac deposition in WT vs Crx-/-. (Wilcoxon Rank Sum Test; ****
p < 2.2 × 10−16)

Additional file 10: Fig. S8. CRX is required to activate Dependent Group
D distal regulatory elements. a Plots display read density of DNase I
experiments centered on CRX-binding site of Dependent and Independent Group D sites. b Analysis of RNA-seq of nearest gene to each peak,
displayed as boxplot of normalized RPKM values at P2 and P21 in WT and
P21 in Crx-/-. (Wilcoxon Rank Sum Test, Paired; *p < 0.05, **p < 2.2 × 10−5,
***p < 2.2 × 10−10, ****p < 2.2 × 10−16) Plots display mean (black line)
and SEM (gray bars) of DNase I data above for CRX Dependent (c) and
Independent (d) sites. (Two-way ANOVA with Tukey multiple comparison
testing; ****p < 0.0001).
Additional file 11: Fig. S9. Sites display different presence of CRX motif
and binding. a Proportion of sites within each of the noted groups that
contains the published CRX motif. (Fisher’s exact test; ***p = 0.0001,
****p < 0.0001) b–d Quantification of read depth of CRX ChIP-seq at
Dependent (red) and Independent (blue) sites within the specified
Groups.
Additional file 12. De novo motif analysis identifies sequences enriched
in different sets of CRX-bound regions. Data presented in columns A–C &
E–I are generated by HOMER (see “Methods”). Column D represents the
scanning of the identified sequence back across the 6 classes of CRX sites
(+/− 1kb from peak center). The plot in line 1 depicts the layout of the
plot, and the y axis quantifies ‘motifs per bp.’
Additional file 13: Fig. S10. TF motifs explain nature of Independent site
activation in absence of CRX. a Heatmap shows unsupervised clustering of [−log10] transformed p-values representing the significance
of representation of the noted TF motif within the set of sites. (* -****)
represent TFs referenced in details in the text. b Quantification of MEF2D
ChIP-seq data at Group C enhancer sites displays loss of signal specifically
at Dependent sites (red) in the Crx−/−. Independent sites (blue) show no
change in signal. Quantifications of CTCF binding over time (c maximum
peak intensity over development and d relative to CRX bindings site at
P21) display consistent signal at Group D Independent sites.
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Abbreviations
CRX: cone rod homeobox protein; NRL: neural retina-specific leucine zipper
protein; ATAC-seq: assay for transposase-accessible chromatin using sequencing; ChIP-seq: chromatin immunoprecipitation followed with deep sequencing; H3K4me3: histone three lysine four trimethylation; H3K27Ac: histone three
lysine twenty-seven acetylation.
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